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240 and 355.bjectives: We previously reported that postoperative hemodynamics and deve
ental outcomes were better among infants randomized to a higher hematocrit
uring hypothermic cardiopulmonary bypass. However, worse outcomes were 
entrated in patients with hematocrit values of 20% or below, and the ben
ematocrit values higher than 25% were uncertain.
ethods: We compared perioperative hemodynamics and, at 1 year, developm
utcome and brain magnetic resonance imaging in a single-center, randomized
f hemodilution to a hematocrit value of 25% versus 35% during hypoth
adiopulmonary bypass for reparative heart surgery in infants undergoing 2-v
le repairs without aortic arch obstruction.
esults: Among 124 subjects, 56 were assigned to the lower-hematocrit strategy (2
 3.1%, mean  SD) and 68 to the higher-hematocrit strategy (32.6%  3.5%). Infants
andomized to the 25% strategy, compared with the 35% strategy, had a more 
ntraoperative fluid balance (P  .007) and lower regional cerebral oxygen saturatio
0 minutes after cooling (P  .04) and onset of low flow (P  .03). Infants with
extro-transposition of the great arteries in the 25% group had significantly 
ospital stay. Other postoperative outcomes, blood product usage, and adverse 
ere similar in the treatment groups. At age 1 year (n  106), the treatment groups h
imilar scores on the Psychomotor and Mental Development Indexes of the B
cales; both groups scored significantly worse than population norms.
onclusions: Hemodilution to hematocrit levels of 35% compared with thos
5% had no major benefits or risks overall among infants undergoing 2-ve
epair. Developmental outcomes at age 1 year in both randomized groups
elow those in the normative population.
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Dognitive impairment and hemodynamic instability
after infant heart surgery with cardiopulmonary by-
pass (CPB) have been associated with hemodilution
o very low hematocrit values during hypothermic CPB in
eparative infant heart surgery.1 However, the optimal he-
atocrit for use during hypothermic CPB is unknown. To
xplore the influence of hemodilution during hypothermic
PB on cognitive outcomes, we1 previously conducted 
andomized trial of hemodilution to a hematocrit value of
pproximately 20% versus 30% in infants less than 9
onths of age undergoing reparative cardiac operations.
emodilution to 20% produced outcomes inferior to those
t 25% or greater, but we could not determine a specific
arget hematocrit level greater than 25% that was optimal.
n the basis of these findings, the Data and Safety Moni-
oring Board, appointed by the National Institutes of Health,
topped our trial of 20% versus 30% hematocrit values and
dvised us to perform a randomized comparison of 25%
ersus 35% hematocrit values. In the current prospective,
andomized, single-center trial, we compared early postop-
rative course and neurodevelopmental outcome at age 1
ear after hemodilution to a hematocrit level of approxi-
ately 25% versus 35% during hypothermic CPB in infants
ndergoing reparative cardiac operations.
aterials and Methods
nrollment of Patients
e enrolled patients between April 2001 and July 2004 at Children’s
ospital Boston. Eligibility criteria included reparative heart surgery
t less than 9 months of age in three diagnostic groups: (1) dextro-
ransposition of the great arteries (D-TGA), (2) tetralogy of Fallot with
r without pulmonary atresia or truncus arteriosus, and (3) ventricular
eptal defect (VSD) or complete common atrioventricular canal de-
ect. Exclusion criteria included birth weight less than 2.3 kg, recog-
izable phenotypic syndrome of congenital anomalies, extracardiac
nomalies of greater than minor severity, previous cardiac surgery, or
ssociated cardiovascular anomalies necessitating aortic arch recon-
truction or additional open surgical procedures before the planned
evelopmental follow-up. Fluorescent in situ hybridization studies
Abbreviations and Acronyms
CPB  cardiopulmonary bypass
D-TGA  dextro-transposition of the great arteries
DTI  diffusion tensor imaging
MDI Mental Development Index
MRI magnetic resonance imaging
MRS magnetic resonance spectroscopy
PDI  Psychomotor Development Index
PRISM Pediatric Risk of Mortality
TOF  tetralogy of Fallot
VSD  ventricular septal defectere not performed on all enrolled infants. Parental informed consent A
48 The Journal of Thoracic and Cardiovascular Surgery ● Febras obtained according to the guidelines of our institutional review
oard.
tudy Design
articipating infants were randomly assigned to undergo hemodi-
ution to a hematocrit level of approximately 25% versus 35%,
ith stratification according to surgeon and diagnostic group.
andomization schemes were developed with a permuted blocks
esign. The surgeons, anesthesiologists, cardiac intensivists, neu-
ologists, and developmental psychologists were blinded to patient
reatment assignment.
nesthesia and Perfusion Methods
nesthetic management and other aspects of perfusion on CPB
ere identical for both treatment groups. The pH-stat strategy was
sed during core cooling, low-flow hypothermic perfusion, and
ewarming up to 30°C.2 We used conventional ultrafiltration du-
ng CPB, but not modified ultrafiltration after CPB. Details of
nesthesia and perfusion methods are provided in Appendix E1.
tudy Outcomes
ppendix E1 contains detailed methods regarding measurement of
tudy outcomes. In the perioperative period, these included re-
ional cerebral oximetry; transcranial Doppler; serum lactate lev-
ls; cardiac output by thermodilution technique3; daily collection
f data including events, medications, respiratory status, laboratory
tudies, fluid inputs and outputs, and blood product requirements;
ioelectric impedance4; inotrope score3; and Modified Pediatri
isk of Mortality–III (PRISM III) scores.5 At 1 year of follow-u
utcomes include neurologic examination (also performed preop-
ratively); brain magnetic resonance imaging (MRI), including
ualitative evaluation, and volumetric,6-8 diffusion tensor imaging
DTI),9 and spectroscopy data10,11; and developmental evaluatio
ncluding the Bayley Scales of Infant Development,12 which yields
cores on two indexes: the Psychomotor Development Index (PDI)
nd the Mental Development Index (MDI).
tatistical Analyses
he treatment groups were compared in intention-to-treat analyses.
econdary analyses examined the effect of hematocrit level at the
nset of low-flow CPB as a continuous variable. All analyses were
djusted for diagnostic group. Primary outcome variables were
erum lactate levels measured 60 minutes after CPB in the peri-
perative period and PDI scores at age 1 year. (See online Appen-
ix for full details.)
esults
f 270 infants who met eligibility criteria, 126 (47%) were
nrolled in the study. Among the 144 remaining eligible
atients, 88 families declined study participation, 55 under-
ent surgery before informed consent could be obtained,
nd 1 was enrolled in a competing study. Two subjects were
xcluded post hoc; 1 subject with D-TGA/VSD had a Ras-
elli procedure performed rather than an arterial switch
peration, and another with D-TGA/VSD was determined
ntraoperatively to have a coarctation that required repair.
mong the remaining 124 study subjects, 56 were assigned
uary 2008
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Do the 25% hematocrit group and 68 to the 35% hematocrit
roup. The slight imbalance in randomized assignments
esulted from the use of the permuted blocks design with
tratification by surgeon and diagnostic group. Demo-
raphic characteristics and preoperative history were similar
n the treatment groups (Table 1).
ntraoperative Data
lthough the treatment groups differed significantly with
egard to the mean hematocrit value at the onset of low-flow
PB (P .001; Table 1), hematocrit levels were similar
0 minutes after cessation of CPB (Figure E1). The 
ABLE 1. Perioperative and operative characteristics acco
ariable
reoperative characteristics
Birth weight (kg)
Gestational age (wk)
Apgar score at 5 min
Age at operation (d), median (range)
Sex (% male)
Race (% nonwhite)
Diagnosis, n (%)
D-TGA, IVS
D-TGA, VSD
TOF
TOF, PA
Truncus arteriosus
VSD
Complete common AV canal
Ever intubated (%)
Intubated at surgery (%)
Overall neurologic exam evaluation (% abnormal)
perative characteristics
Hematocrit level at induction (%)
Hematocrit level at onset of low-flow bypass (%)
Crossclamp time (min)
Total support time (min)
Total bypass time (min)
Low-flow bypass time (min)
Duration of circulatory arrest (min), median (range)
None, n (%)
1–10
11–30
31–44
 45
luid balance (in minus out) (mL)
ntraoperative blood products (mL), median (range)
-TGA, Dextro-transposition of the great arteries; IVS, intact ventricular s
tresia; AV, atrioventricular; SD, standard deviation. *P  .001 for differen
djustment for diagnosis group. †P.007 for difference between treatment
roup.ent groups were also similar in durations of crossclamp- p
The Journal of Thoracic-
ng, total support, total bypass, low-flow bypass, and circu-
atory arrest; in the rates of cooling and rewarming; and in
H and carbon dioxide levels and tympanic temperatures
efore and during CPB.
Infants randomized to the 25% strategy, compared with
he 35% strategy, had a more positive intraoperative fluid
alance (P  .007; Table 1). They also had lower m
lood pressure at induction (58  25 vs 66  19 mm Hg;
 .05), at onset of bypass (40  12 vs 46  15 mm Hg;
 .02), and at onset of low-flow bypass (28  10 vs 32
11 mm Hg; P  .07). However, the differences in mean
lood pressure from the time of induction to these time
g to treatment group
25% Hematocrit (n  56) 35% Hematocrit (n  68)
Mean  SD
3.5 0.6 3.4 0.5
39.2 1.3 39.2 1.2
8.5 1.1 8.7 0.7
32 (2–239) 41 (2–264)
61 65
25 16
15 (27) 11 (16)
10 (18) 14 (21)
15 (27) 21 (31)
1 (2) 2 (3)
2 (4) 3 (4)
12 (21) 16 (24)
1 (2) 1 (1)
34 37
11 12
66 50
35.0 6.8 35.5 6.4
24.8 3.1 32.6 3.5*
69 28 65 29
110 38 105 42
100 33 95 33
50 29 46 25
1 (0–44) 0 (0–59)
28 (50) 40 (59)
9 (16) 6 (9)
15 (27) 15 (22)
4 (7) 6 (9)
0 1 (1)
535 220 403 265†
246 (55–650) 239 (50–866)
; VSD, ventricular septal defect; TOF, tetralogy of Fallot; PA, pulmonary
tween treatment groups, determined by means of linear regression with
s, determined by means of linear regression with adjustment for diagnosisrdin
eptum
ce be
groupoints were similar in the treatment groups.
and Cardiovascular Surgery ● Volume 135, Number 2 349
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DTen minutes after the onset of cooling, serum osmolality in
he 25% hematocrit group tended to be lower than in the 35%
ematocrit group (297 4 vs 298 6 mOsm/L; P .06), but
his difference may not be clinically important. Osmolalities
ere similar at the other two points measured (ie, after induc-
ion and on reaching 35°C tympanic). Intraoperative ionized
alcium was significantly lower in the 25% hematocrit group
0 minutes after the start of rewarming (0.92 0.50 vs 1.24
.55 mmol/L; P.001) and during warm flow, when reaching
5°C tympanic (1.40  0.26 vs 1.55  0.31 mmol/L; P 
008). Ionized calcium was similar in the two groups by 60
inutes after cessation of bypass, however.
Intraoperative total blood product use was similar be-
ween treatment groups.
Infants in the 25% hematocrit group, compared with
hose in the 35% hematocrit group, had lower regional
xygen saturation at 10 minutes after cooling (84%  9%
s 88%  9%; P  .04) and onset of low flow (84%  9%
s 88%  9%; P  .03), as well as a tendency to be lower
t the start of rewarming (82%  12% vs 86% 12%; P
08), 10 minutes after start of rewarming (79%  17% vs
2%  13%; P  .06), and at resumption of CPB at full
ow (81%  14% vs 85%  11%; P  .07); regional
xygen saturation was similar at cessation of bypass, as well
s at 60 minutes, 6 hours, and 18 hours later. There were no
ignificant differences in systolic, diastolic, or mean cere-
ral blood flow velocity by transcutaneous cerebral Doppler
t any time intraoperatively or up to 18 hours postopera-
ively (data not shown).
ostoperative Course
erum lactate values 60 minutes after cessation of bypass
ere not associated with treatment assignment (P  .84;
able 2, Figure E2) or with continuous hematocrit lev
he onset of low-flow bypass. After stepwise linear regres-
ion modeling, higher serum lactate levels were related to
onger duration of circulatory arrest (P  .001), age at
ABLE 2. Postoperative course according to treatment gro
ariable 25% Hema
actate 60 min after bypass 2.9
mpedance % change from preoperative
to postoperative day 1
35
verage inotrope score over first 24 hours 10.8
ostoperative blood products (total) (mL) 96 (
ays intubated 1.5 (
ays in intensive care unit 3 (
ays in hospital 7 (
P values determined by means of linear regression are for differences
etermined by means of Wilcoxon rank sum tests are for differences beturgery less than 15 days (P  .002), preoperative intuba- h
50 The Journal of Thoracic and Cardiovascular Surgery ● Febrt
ion (P  .002), and later calendar date of operation (P 
04), but not with treatment randomization (P  .45). The
ematocrit groups also had similar mean lactate levels at 3,
, 12, 18, and 24 hours postoperatively (data not shown).
The average hourly inotrope score over the first 24 hours
ostoperatively was lower among patients in the 25% he-
atocrit group than the score among those in the 35% group
P  .05; Table 2). There were no significant differen
etween treatment groups in modified PRISM III score at 12
nd 24 hours or in percent increase in total body water,
easured by percent fall in bioelectric impedance from the
reoperative period to the first postoperative day. Cardiac
utputs were measured by thermodilution every 3 hours
ostoperatively in a small subgroup of patients (n 38), but
here were no significant differences or suggestive trends
etween the treatment groups at any point or in their nadir.
imilarly, the uses of blood and blood products were similar
n the treatment groups. Differences between the treatment
roups in durations of tracheal intubation or time until
ischarge from the intensive care unit or hospital did not
each statistical significance (Table 2).
No infants died or had clinical seizures, and the hemat-
crit groups were similar with respect to other serious
dverse events (Table 3). There were no adverse events
ere possibly or definitely related to treatment assignment
r to the study protocol.
esting at 1 Year
f 124 study children, 2 lived outside the country and were
ot invited for 1-year follow-up. Of the remaining 122
amilies, 15 refused to participate, 1 completed question-
aires only, and 106 underwent in-person evaluation. Those
ho were evaluated, compared with those who declined,
ad parents with significantly higher education (P  .04)
nd longer hospital stays (P  .04), but were otherwise
imilar in perioperative characteristics. Subjects random-
zed to the 25% hematocrit group, compared with the 35%
(n  56) 35% Hematocrit (n  68) P value*
Mean  SD
.7 2.8  1.4 .84
5 30  30 .23
.8 12.6 5.0 .05
Median (interquartile range)
8) 105 (45, 180) .38†
.2) 1.7 (1.1, 2.7) .90†
3 (2–4) .87†
6 (5–8) .14†
een treatment groups with adjustment for diagnosis group. †P values
treatment groups with adjustment for diagnosis group.up
tocrit
 1
 2
 5
65, 16
1.1, 3
2–5)
6–9)
betwematocrit group, had similar age- and sex-adjusted height
uary 2008
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Dercentiles (34%  31% vs 39%  28%; P  0.39) and
eight percentiles (36%  31% vs 43%  32%; P  .15).
PDI scores were similar in the treatment groups (Tab
igure E3); scores in both groups were much lower tha
opulation norms (P  .001). In models examining the
ffect of hematocrit level as a continuous variable, no sta-
istically significant associations were found (Figure E
fter stepwise linear regression modeling, higher PDI
cores were related to higher birth weight (P.005) but not
o treatment assignment (P  .85) or diagnostic group.
MDI scores also did not differ significantly among the
reatment groups (Table 4, Figure E3) and were significa
ower than population means (P  .001). In models exam-
ning the effect of hematocrit level as a continuous variable,
o statistically significant associations were found. After
tepwise linear regression modeling, higher MDI scores
ere related to higher birth weight (P  .001) and higher
amily social class (P  .01), but not to treatment assign-
ent (P  .19) or diagnostic group.
Abnormal results of neurologic examinations were com-
on but did not differ in frequency between the treatment
roups (57% in each group, Table 5). The most com
ABLE 3. Adverse events according to treatment group*
ariable
25% Hematocrit
(n  56)
35% Hematocrit
(n  68)
P
value†
No. with adverse event (%)
eath 0 0
ardiac arrest 0 0
hest opened in cardiac
intensive care unit
3 (5) 0 .10
horeoathetosis 0 0
omplete heart block 0 1 (1) .40
xtracorporeal membrane
oxygenation
0 0
eoperation 1 (2) 0 1.0
epatic dysfunction (AST
or ALT  400 IU)
0 1 (1) .40
ediastinitis 0 0
ecrotizing enterocolitis 0 1 (1) .40
enal failure (creatinine
 1.5)
0 0
espiratory arrest 0 0
linical seizures 0 0
troke 0 0
amponade 1 (2) 0 1.0
entricular fibrillation 1 (2) 0 .41
ST, Aspartate aminotransferase; ALT, alanine aminotransferase. *All ad-
erse events occurred in patients with dextro-transposition of the great
rteries, except for ventricular fibrillation, which occurred in an infant with
runcus arteriosus. †P values, determined by means of stratified exact
ests, are for differences between treatment groups with adjustment for
iagnostic group.eason that the examination was classified as showing ab- P
The Journal of Thoracic,
e
ormal results was because of abnormalities in motor
unction.
Of the 106 who underwent 1-year evaluation, 48 (45%)
ad a brain MRI. Missing MRI scans were due to parental
efusal usually related to the need for general anesthesia (55
hildren, 52%), cancellations by the anesthesiologist result-
ng from medical concerns (2, 2%), and unavailability of an
RI (1, 1%). Subjects who had an MRI scan were similar,
n terms of PDI and MDI scores, as well as head circum-
erence, to those subjects whose parents declined the MRI
can. Results were classified with respect to both anatomic
bnormalities and volumetric and DTI analyses (Table
ocal or multifocal abnormalities, typically minor findings
uch as tiny foci suggestive of small amounts of hemosid-
rin, were detected in 19 (40%) children in the combined
reatment groups. Diffuse abnormalities were less common,
nd periventricular leukoencephalopathy was found only in
child in each treatment group. Minor developmental ab-
ormalities were detected in 4 children.
For the quantitative MRI analysis (Table 6), we adjuste
oth diagnosis group and age at the time of MRI scan, because
RI measures change with age owing to normal brain matu-
ation. For the volumetric analysis, the treatment groups did
ot differ significantly in their overall volume of gray or white
atter, cerebrospinal fluid, or the total volume of the brain,
erebrum, or cerebellum. Regional analysis of brain volumes
howed that the 25% hematocrit group, compared with the
5% hematocrit group, had significantly smaller gray matter
olumes in the left and right premotor (P  .02 and P  .05,
espectively) and left and right subgenual regions (P .02 and
ABLE 4. Scores on developmental tests according to
reatment group
est
25% Hematocrit
(n  48)
35% Hematocrit
(n  58)
P
value*
Mean  SD
sychomotor Development
Index
87.0 15.4 86.6 16.3 .99
ental Development Index 93.7 11.5 95.6 12.0 .38
No. with low score/total no.
(%)
sychomotor Development
Index
85 21/48 (44) 25/58 (43) .85
70 9/48 (19) 10/58 (17) .79
ental Development Index
85 9/47 (19) 12/57 (21) 1.0
70 1/47 (2) 1/57 (2) 1.0
P values are for differences between treatment groups, with adjustment
or diagnosis group; P values were determined by means of linear regres-
ion for continuous outcome variables and stratified exact tests for di-
hotomous outcome variables. .003, respectively). There were no differences in white
and Cardiovascular Surgery ● Volume 135, Number 2 351
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Datter or cerebrospinal fluid volumes in these regions. We
ound no significant differences between treatment groups in
he apparent diffusion coefficient or fractional anisotropy in
ny regions analyzed by DTI and no differences in the T2
alue for water or metabolite concentrations measured by
agnetic resonance spectroscopy (MRS).
-TGA Subgroup Analysis
ecause infants with D-TGA are relatively homogeneous,
arely have chromosomal abnormalities, and have longer
ABLE 5. Neurologic abnormalities according to treatmen
ariable 2
verall abnormal examination result
ead circumference
Microcephaly
Macrocephaly
pecial senses (visual or auditory)
ranial nerves (oculomotor or facial oromotor function)
otor function (strength, tone, reflexes)
P values, determined by means of stratified exact tests, are for differenc
ABLE 6. Qualitative and quantitative evaluation of magne
ariable
ualitative analysis
Focal or multifocal abnormalities
Focal infarction or atrophy
Brain mineralization/hemosiderin
Diffuse abnormalities
Delayed myelination
Ventriculomegaly
T2 hyperintensities/gliosis/periventricular leukomalacia
Developmental abnormalities
Major malformation
Minor malformation
uantitative analysis
Head circumference (cm)
Volumetric analysis (total, mL)
Gray matter
Subcortical gray matter
Myelinated white matter
Unmyelinated white matter
CSF
Intracranial (brain  CSF)
Brain
Cerebrum
Cerebellum
Spectroscopy analysis
T2 (ms)
N-acetyl aspartate (mmol/L)
SF, Cerebrospinal fluid. *P values, determined by means of stratified e
iagnosis group. †P values, determined by means of linear regression, are
nd age at evaluation by magnetic resonance imaging.
52 The Journal of Thoracic and Cardiovascular Surgery ● Febrntraoperative support times, the impact of different perfu-
ion strategies might be easier to detect within this diagnos-
ic group. Infants with D-TGA randomized to the 25%
ematocrit group, compared with infants in the 35% hemat-
crit group, had significantly longer duration of hospitaliza-
ion (median 9 days, interquartile range 7–10 days, vs
edian 7 days, interquartile range 6–9 days; P  .04). No
ther perioperative or 1-year outcome variables differed
mong D-TGA patients assigned to the two treatment
roups, although statistical power was limited.
up
ematocrit (n  47) 35% Hematocrit (n  53) P value*
No. with abnormality/total no. (%)
27/47 (57) 30/53 (57) .84
.42
0/47 2/53 (4)
2/47 (4) 2/53 (4)
0/47 1/53 (2) .44
3/46 (7) 5/53 (9) .72
25/46 (54) 25/53 (47) .42
tween treatment groups with adjustment for diagnosis group.
sonance imaging outcomes according to treatment group
Hematocrit (n  25) 35% Hematocrit (n  23) P value*
No. with abnormality (%)
9 (36) 10 (43) 1.0
1 (4) 0
8 (32) 10 (43)
2 (8) 1 (4) 1.0
1 (4) 0
1 (4) 0
1 (4) 1 (4)
1 (4) 3 (13) 1.0
0 0
1 (4) 3 (13)
Mean  SD
46.1 1.6 46.4 1.3 .37†
599 63 628  58 .08†
32 10 33  10 .65†
76 28 83  39 .42†
181 40 170  45 .61†
100 34 103  33 .55†
988 99 1017 106 .16†
888 88 914  93 .18†
789 82 812  85 .20†
99 10 102 11 .19†
99 6 100 5 .66†
7.7 2.4 7.9  1.4 .90†
ests, are for differences between treatment groups with adjustment for
ifferences between treatment groups with adjustment for diagnosis groupt gro
5% Htic re
25%
xact t
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Discussion
e found that neonates and infants assigned to the 25%
ompared with the 35% hematocrit strategy had similar early
ostoperative hemodynamic and later neurodevelopmental
utcomes. Infants randomized to the 25% strategy, compared
ith the 35% strategy, had greater positive fluid balance from
he onset to cessation of bypass; lower serum osmolality during
he cooling phase of bypass; lower intraoperative perfusion
ressures; and lower ionized calcium during rewarming and
arm flow. They also had significantly lower regional oxygen
aturation at 10 minutes after cooling and onset of low flow, as
ell as a tendency to be lower at the start of rewarming, 10
inutes after start of rewarming, and at resumption of CPB at
ull flow. However, the clinical significance of these differ-
nces is likely to be negligible because the actual regional
xygen saturation values were high and well above a 45%
hreshold for neurologic injury recently reported.13 A slightly
igher 24-hour inotrope score among infants in the 35% group
as not associated with adverse clinical outcomes. A pre-
pecified subgroup analysis demonstrated that infants with
-TGA randomized to the 35% hematocrit group, compared
ith the 25% group, were discharged from the hospital signif-
cantly sooner. Otherwise, the treatment groups had no signif-
cant differences or suggestive trends in other early postoper-
tive outcomes, including blood product usage and adverse
vents. At age 1 year, the treatment groups had similar MDI
nd PDI scores; developmental scores in both treatment groups
ere highly significantly worse than the population norms.
hus, hemodilution to hematocrit levels of 35% compared
ith 25% had no significant clinical benefits or risks overall
mong infants undergoing 2-ventricle repair without aortic
rch reconstruction.
Both qualitative and quantitative analyses of MRI data
btained in a subset of our population showed no major
ifferences between treatment groups. This finding suggests
hat overt acquired brain injury detectable by MRI could not
e attributed to hematocrit strategy. The small but statisti-
ally significant differences in gray matter volume found in
wo regions (premotor and subgenual) will require further
nalysis with regard to their relationship to functional out-
ome. Interestingly, a reduced volume in the premotor re-
ion (gray and white matter combined) was correlated with
Q in one previous study of the effect of premature birth on
rain volumes in childhood.14 However, we found no d-
erence in neurodevelopmental outcome between treatment
roups in our study; hence, the small volume differences we
ound probably represent a minor effect. The potential sig-
ificance of these findings will be addressed in future work.
inally, previous investigations have reported a high inci-
ence of embolic stroke15 and periventricular leukoenceph-
lopathy16,17 in similar populations studied by brain M
e did not perform preoperative or early postoperative
rain MRIs. Therefore, we cannot determine whether the
The Journal of Thoracicbsence of infarction and the low prevalence of periven-
ricular leukoencephalopathy in our study population are
elated to institutional differences in perioperative manage-
ent or resolution of findings that had been present earlier.
We excluded infants who were believed or proven to
ave genetic syndromes during routine clinical care, but we
id not perform fluorescent in situ hybridization studies on
ll infants. Genetic and other patient factors have been
ighly associated with low developmental scores among
nfants undergoing heart surgery,18 and it is likely that su
actors explain, in part, the low developmental scores of
nfants in both treatment groups at age 1 year. Because the
redictive validity of infant neurocognitive testing is lim-
ted, it is possible that differences between the two hemodi-
ution strategies could emerge with longer follow-up.19,20
owever, the predictive validity of the Bayley Scales is
etter in high-risk infants than that in normal children21,22
nd we have seen treatment differences in other randomized
rials of other aspects of perfusion strategies. Our study
ample excluded children with other known risk factors for
dverse neurodevelopmental outcome. This, together with
he single-center design and exclusion of the highest risk
nfants with single ventricle, may limit the generalizability
f the findings.
In summary, early postoperative and 1-year developmen-
al outcomes are similar among infants undergoing repara-
ive cardiac operations using hemodilution to hematocrit
evels of 35% compared with 25%, although intraoperative
uid accumulation is greater with a lower hematocrit value.
dministration of blood products and occurrence of adverse
vents are comparable with these hemodilution strategies.
nfants with D-TGA in the 35% hematocrit group had a
horter hospital stay, although they did not differ with
espect to other outcome variables. Overall, in infants un-
ergoing repair of congenital heart disease with 2 ventricles
nd without aortic arch obstruction, higher versus lower
ematocrit levels within the range of 25% to 35% have no
ignificant advantages or disadvantages.18
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D-Appendix: Methods
Anesthesia and perfusion methods. After induction of
nesthesia and placement of an arterial catheter, surface cooling
as initiated with a low ambient room temperature, a cooling
attress, and ice packs to the head. CPB and core cooling were
egun as soon as the venous and aortic cannulas were in place.
atients had variable periods of full-flow CPB at approximately
.5 L · min1 · m2 when cooling to various levels of hypothermia
nd usually during rewarming. Some patients had periods of deep
ypothermic circulatory arrest, and most had at least one period of
educed-flow CPB, for example, at approximately 0.75 L · min1
m2 when at deep hypothermia (rectal temperature  18°C).
ypothermic myocardial protection was provided by infusion of
xygenated crystalloid cardioplegic solution (Plegisol; Abbott
aboratories, North Chicago, Ill) usually as a single dose of 20
L/kg or a custom mix of 4 parts crystalloid (Baxter Compass,
dison, NJ) to 1 part blood. After patient randomization, hemodi-
ution was achieved with whole blood and Plasma-Lyte A pH 7.4
Multiple Electrolytes Injection, Type 1, USP). Standard perfusion
alculations were used to determine the volumes of the priming
onstituents, with the aim of obtaining a hematocrit level of 25%
r 35% at the time of onset of low-flow CPB. The pH-stat strategy
as used during core cooling, low-flow hypothermic perfusion,
nd rewarming up to 30°C.E1 Anesthetic management and othe
spects of perfusion on CPB were identical for both treatment
roups. We used conventional ultrafiltration during CPB, but not
odified ultrafiltration after CPB.
Regional cerebral oximetry. Regional cerebral oxygen sat-
ration was measured with the INVOS 5100 spectrometer (Soma-
etics; Troy, Mich). The INVOS 5100 is a continuous-wave spec-
rometer and uses two wavelengths of near-infrared light (730 and
10 nm) to measure the ratio of oxyhemoglobin to total hemoglo-
in. The cerebral oxygen saturation is expressed as the regional
xygen saturation, the scale unit of which is percent. After the
nduction of anesthesia, Pediatric SomaSensors (Somanetics, Troy,
ich) were placed on the right and the left sides of the forehead
ccording to the manufacturer’s guidelines. After an accommoda-
ion period, data collection was begun and downloaded to storage
isk every 10 seconds throughout the case for further analysis.
Transcranial Doppler. A 2-MHz, range-gated, pulsed-wave
ranscranial Doppler sonographic probe (Multi-Dop T; DWL Ele-
tronische Systeme GmbH, Sipplingen, Germany) was placed over
he right (rarely the left) temporal window to measure cerebral
lood flow velocity in the proximal (M1) segment of the middle
erebral artery. To ensure a reproducible window, we adjusted the
ignal from the artery to be accompanied by retrograde anterior
A1 segment) cerebral artery flow. After an acceptable waveform
ad been achieved, the probe position was secured with an adhe-
ive tape and head bandage. Meticulous care was taken to ensure
constant position, insonation depth, sample volume, gain, and
ower of ultrasound for all measurements. Peak systolic flow
elocity (VS), mean flow velocity (VM), and peak end-diastolic
ow velocity (VD) were measured during hemodynamically stable
ntervals, with constant recordings of at least 15 seconds’ duration,
t 6 time points: after induction, at heparin administration, 10
inutes after cooling on CPB, 10 minutes after start of rewarming
n CPB, rewarmed to 35°C on CPB, 60 minutes off CPB, 6 hours
fter CPB, and 18 hours after CPB. Middle cerebral artery pulsa- u
The Journal of Thoracic aility index (PI) and resistance index (RI) were calculated accord-
ng to the following formulas:
PI  [VS – VD]/VM
RI  [VS – VD]/VS
In addition, mean arterial pressure, PaCO2, pH, bypass flow
ates, and tympanic, esophageal, and rectal temperatures were
ecorded at the same times.
Early postoperative data. We measured serum lactate 60
inutes after CPB, as well as at 3, 9, 12, 18, and 24 hours
ostoperatively. During the first 24 hours after surgery, cardiac
utput was determined by the thermodilution techniqueE2 at 3-hour
ntervals. During the study period, cardiac outputs were measured
rimarily in the patients of one participating surgeon (R.A.J.), for
hom placement of a thermodilution catheter was performed as
art of routine clinical care. The study nurses recorded daily data
n events, medications, respiratory status, laboratory studies, fluid
nputs and outputs, and blood product requirements. Bioelectric
mpedance was measured preoperatively and on the first postop-
rative day to estimate total body water.E3 Inotrope score, modified
rom Wernovsky and associates,E2 was determined for the initi
4 hours postoperatively. Modified PRISM III scores were also
alculated for each patient at 12 and 24 hours postoperatively.E4
Neurologic examination. Neurologic examination was per-
ormed before surgery and at 1-year follow-up according to a
niform protocol. Patients were classified as having abnormal
esults of the neurologic examination if definite abnormalities were
oted in any of the following categories: head circumference,
ental status, special senses, cranial nerve motor function, or
eripheral motor function.
Brain MRI. MRI scans were acquired at 1 year of age.
onventional MRI data were obtained for qualitative evaluation,
nd volumetric, diffusion tensor, and spectroscopy data were ob-
ained for detailed quantitative analysis of brain structure and
omposition. One neuroradiologist (R.R.) evaluated all the MRI
cans for any congenital or acquired abnormalities. For volumetric
nalysis, a sequence of image processing algorithms was used to
egister and then segment coronal T1-weighted and T2-weighted
RI data into separate tissue classes: cortical and subcortical gray
atter, myelinated and unmyelinated white matter, and cerebro-
pinal fluid.E5,E6 The segmented data were then parcellated into
egions with semiautomated Talairach-based parcellation software,
hich has been validated specifically in infant brain MRI daE7
TI data were obtained by the line scan diffusion imaging tech-
ique.E8 We obtained axial DTI data with 6 directions an
actors of 5 and 750. The apparent diffusion coefficient and frac-
ional anisotropy were measured offline in selected regions of
nterest of the cerebral white matter (frontal, central, and posterior
hite matter, optic radiations, posterior limb of the internal cap-
ule, and the genu and splenium of the corpus callosum). Finally,
e obtained single voxel proton MRS to measure the concentra-
ion of specific metabolites in the left posterior cerebral white
atter that may be altered by injury. Three MRS sequences were
btained sequentially with echo time values of 31, 135, and 270 ms
repetition time1500, voxel volume 1.5 cm3). We calculated the T2
alue for water (in milliseconds, using the water unsuppressed
pectra) and calculated the absolute metabolite concentrations of
holine, creatine, and N-acetyl aspartate (in millimoles per liter)
sing the water standardization method.E9,E10
nd Cardiovascular Surgery ● Volume 135, Number 2 354.e1
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DDevelopmental evaluation. Two examiners administered
he Bayley Scales of Infant Development,E11 which yields score
n two indexes: the PDI and the MDI. We also calculated the
roportion of children whose scores were 85 or 70 (at least 1 SD
r 2 SD below the population mean, respectively).
Statistical analyses. The treatment groups were compared in
ntention-to-treat analyses. Secondary analyses examined the ef-
ect of hematocrit level at the onset of low-flow CPB as a contin-
ous variable. For patients in whom low-flow bypass was not used,
e analyzed the hematocrit level 10 minutes after onset of cooling.
ll tests of hypotheses and regression analyses of outcome vari-
bles were adjusted for diagnostic group (D-TGA, tetralogy of
allot, and VSD groups). Volumetric, diffusion tensor, and spec-
roscopy MRI outcome variables were also adjusted for age at MRI
valuation. We also assessed potential interactions between he-
odilution treatment assignment and diagnostic group on out-
omes. Primary outcome variables were serum lactate levels mea-
ured 60 minutes after CPB in the perioperative period and PDI
cores at age 1 year.
Outcomes included both continuous and categorical variables.
inear regression and exact stratified Wilcoxon tests were used to
nalyze continuous variables. Stratified exact tests and logistic
egression methods were used to analyze categorical variables. In
ddition to diagnostic group, we performed analyses assessing
hether other potential predictor variables confounded the effects
f hemodilution on primary outcome variables. These predictor
ariables included surgeon, sex, age at the time of the operation,
nterval between the operation and developmental examination,
irth weight, maternal and paternal education, family social class,
estational age, Apgar scores at 1 and 5 minutes, preoperative
ntubation, preoperative acidosis, calendar date of the operation,
reoperative neurologic examination results, type of cardioplegic
olution, lowest tympanic temperature, duration of circulatory
rrest, total bypass time, total support time, and individual per-
orming developmental testing.
All P values are 2-tailed. A sample size of 60 subjects per
reatment group provides 78% power to detect a half SD difference
effect size 0.5 SD units) and 91% power to detect an effect size
f 0.6 SD units between treatment groups in either lactate levels or
DI scores.
We are indebted to members of our Data and Safety Monitoring
oard: Welton Gersony, MD (Chairman), Nathan J. Blum, MD,
54.e2 The Journal of Thoracic and Cardiovascular Surgery ● Ferle Austin, MD, Sally A. Hunsberger, PhD, John P. Lantos, MD,
nd Eli Mizrahi, MD; Haim Bassan, MD, and Cecil Hahn, MD, for
onducting neurologic examinations; our perfusionists: Willis G.
ieser, CCP, Robert A. LaPierre, BS, CCP, Robert J. Howe, BS,
CP, Gregory S. Matte, CCP, and William L. Regan; our nursing
taff in the Cardiac Intensive Care Unit for assistance with adher-
nce to the protocol; families and children in the cohort for their
ime and effort; Ludmila Kyn for database and statistical program-
ing; Donna Donati, Donna Duva, and Lisa-Jean Buckley for data
anagement; and Kathleen Alexander for project coordination.
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DFigure E1. Plot of serial measurements of hematocrit according to perfusion phases, defined as follows: 1  after
induction of anesthesia; 2  heparin given; 3  10 minutes after onset of cooling; 4  onset of low-flow bypass;
5  10 minutes after onset of rewarming; 6  start of warm flow; 7  60 minutes off bypass. Values are depicted
as the mean  1 standard deviation. After adjustment for diagnostic group, statistically significant differences
were found for phases 3, 4, 5, and 6.
Figure E2. Box plots of serum lactate levels measured 60 minutes after cessation of cardiopulmonary bypass
according to hematocrit group. The solid bar within the box represents the median value, the upper boundary of
the box the 75th percentile, and the lower boundary of the box the 25th percentile. The vertical lines extend to the
10th and 90th percentiles, with more extreme observations plotted as circles. The linear regression P value shown
is for the effect of hematocrit group on lactate level, with adjustment for diagnostic group.
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Digure E3. Box plots of Psychomotor Development Index and Mental
evelopment Index scores at 1 year, according to hematocrit group. The
olid bar within the box represents the median value, the upper bound-
ry of the box the 75th percentile, and the lower boundary of the box the
5th percentile. The vertical lines extend to the 10th and 90th percen-
iles, with more extreme observations plotted as circles. The linear
egression P values shown are for the effect of hematocrit group on
utcome, with adjustment for diagnostic group.igure E4. Scatterplot of Psychomotor Development Index scores at 1
ear as a function of hematocrit at the onset of low-flow bypass. The
olid line was derived by linear regression of the data, and the dashed
ines delimit the 95% confidence interval. The linear regression P value
hown is for the effect of hematocrit at the onset of low-flow bypass on
utcome, with adjustment for diagnostic group. Hct, Hematocrit.
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